C71T
CANCELLED SECTION 71
05/08/2026
Back to search
Official data from USPTO
VIROXIS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
47
Latest update
06/02/2026
Trademark type
Word
Nice classes
5, 42
Filing date
03/17/2018
Registration date
10/22/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/08/2026
Last transaction
06/02/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
34
Owner location
Paris, FR
Examiner
GOODWIN, KATRINA JOYE
Law office
N40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
VIROXIS SAS
Representatives
Mari-Elise Paul McBrayer PLLC
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical and veterinary preparations for the treatment of viral and infectious diseases and disordersincluding exogenous and endogenous virusesrejection of transplanted tissuesfeline immunodeficiency virusfeline leukemia virushuman T- lymphotropic virusHIV; chemical preparations for medical or pharmaceutical purposes for the treatment of viral and infectious diseases and disordersincluding exogenous and endogenous virusesrejection of transplanted tissuesfeline immunodeficiency virusfeline leukemia virushuman T-lymphotropic virusHIV
Class 42
Evaluationsassessments and research in the fields of science and technology provided by engineers in the field of pharmaceutical preparations for use in the treatment of humans and animals; research and development for others in the field of pharmaceutical preparations for use in the treatment of humans and animals; technical project studies in the nature of scientific feasibility studies in the field of pharmaceutical preparations for use in the treatment of humans and animals
Publications
History of USPTO decisions and trademark events.
47 publications found
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
10/22/2024
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
04/25/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/25/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
04/25/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/25/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/25/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/25/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/25/2024
RNWL
INTERNATIONAL REGISTRATION RENEWED
02/09/2021
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
05/08/2020
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/10/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/13/2020
FIMP
FINAL DISPOSITION PROCESSED
02/13/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/22/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
10/22/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
10/02/2019
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
10/02/2019
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
09/12/2019
CHPB
POST PUBLICATION AMENDMENT - ENTERED
08/27/2019
APET
ASSIGNED TO PETITION STAFF
08/23/2019
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
08/08/2019
CHPB
POST PUBLICATION AMENDMENT - ENTERED
05/21/2019
APET
ASSIGNED TO PETITION STAFF
05/15/2019
GPNX
NOTIFICATION PROCESSED BY IB
04/26/2019
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
04/15/2019
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
03/14/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/05/2019
PUBO
PUBLISHED FOR OPPOSITION
03/05/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/13/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/13/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/13/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/31/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/22/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/22/2019
ALIE
ASSIGNED TO LIE
01/16/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/11/2019
RFNT
REFUSAL PROCESSED BY IB
08/10/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/13/2018
RFRR
REFUSAL PROCESSED BY MPU
07/13/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/30/2018
CNRT
NON-FINAL ACTION WRITTEN
06/29/2018
DOCK
ASSIGNED TO EXAMINER
06/27/2018
MAFR
APPLICATION FILING RECEIPT MAILED
05/05/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/01/2018
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
04/30/2018
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
04/26/2018
Continuous trademark protection
Get notified about every new filing that threatens VIROXIS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.